Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Genetic Risk of Inflammatory Bowel Disease Appears Distinct in African Americans

By LabMedica International staff writers
Posted on 03 Mar 2021
The inflammatory bowel diseases Crohn’s disease (CD) and ulcerative colitis (UC) arise in the context of inappropriate activation of the intestinal immune system in response to an environmental trigger in individuals who are genetically predisposed.

Genetic discoveries of inflammatory bowel disease have been made primarily in populations of European ancestry and utilizing genome-wide genotype data. More...
This predominance, combined with a focus on common alleles, has left the understanding of the role of rare variants among non-European populations incomplete.

A large team of multi-center multidisciplinary scientists led by the Emory University School of Medicine (Atlanta, GA, USA) sequenced the genomes of nearly 1,800 African Americans with inflammatory bowel diseases (IBD) and more than 1,600 unaffected controls with African ancestry from the USA. All DNA samples investigated in the study (a total of 3,610 before quality control [QC]) were processed and sequenced.

Genomic DNA extracted from the blood of sampled participants was fragmented to a target size of 385 bp fragments via a Covaris Focused-ultrasonicator (Woburn, MA, USA). Completed libraries were quantified with quantitative PCR kit (KAPA Biosystems, Wilmington, MA, USA), normalized to 2.2 nM, and were pooled into 24-plexes. Sample pools were combined with HiSeqX Cluster Amp Reagents EPX1, EPX2, and EPX3, and cluster generation was performed with the Illumina cBot and DNA libraries were sequenced with the HiSeqX sequencing system (Illumina, San Diego, CA, USA).

While the team's search did not unearth new loci with genome-wide significant ties to IBD, the genome sequence data and subsequent fine-mapping analyses suggested that several risk alleles occurred at different frequencies or had different effect sizes in the African American participants compared to individuals of European descent. For example, the major effect at PTGER4 fine maps to a single credible interval of 22 single-nucleotide polymorphisms (SNPs) corresponding to one of four independent associations at the locus in European ancestry individuals, but with an elevated odds ratio for Crohn’s disease in African Americans.

A rare variant aggregate analysis implicates Ca2+-binding neuro-immunomodulator CALB2 in ulcerative colitis. Highly significant overall overlap of common variant risk for inflammatory bowel disease susceptibility between individuals with African and European ancestries was observed, with 41 of 241 previously known lead variants replicated and overall correlations in effect sizes of 0.68 for combined inflammatory bowel disease.

Subra Kugathasan, MD, a professor of pediatrics and human genetics and a senior author of the study, said, “Subtle differences influence the performance of polygenic risk scores, and we show that ancestry-appropriate weights significantly improve polygenic prediction in the highest percentiles of risk.”

The authors concluded that their analyses provide an example of how polygenic analysis needs to be adjusted for ancestry when considering ethnic disparities in healthcare. Frequency distributions of polygenic risk scores can differ markedly across populations, mostly because of deviations in allele frequencies, although ascertainment biases in discovering common variant associations are also a concern. The study was published on February 17, 2021 in the journal American Journal of Human Genetics.

Related Links:
Emory University School of Medicine
Covaris
KAPA Biosystems
Illumina



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.